Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A110-A110, February 1, 2025. Background:Recent studies have shown that the autonomic nervous system plays a crucial role in regulating the initiation and progression of atherosclerosis in peripheral arteries.

Atherosclerosis 40

Atherosclerosis Plaque Stroke Strokes 40

Circulation

MARCH 23, 2025

Circulation, Volume 151, Issue 12 , Page e764-e764, March 25, 2025.

Article 49

Article Dementia Atherosclerosis Circulation 49

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP203-AWP203, February 1, 2025. Evidence has shown that carotid artery geometries are independently associated with ipsilateral MCA atherosclerosis. Introduction:The middle cerebral artery (MCA) is the most common site for inrtacranial atherosclerotic stenosis. 21.35), p<0.001).Conclusions:Both

Atherosclerosis 40

Atherosclerosis Stenosis Risk Factors BMI 40

Circulation

MARCH 23, 2025

Circulation, Volume 151, Issue 12 , Page e766-e766, March 25, 2025.

Article 49

Article Dementia Atherosclerosis Circulation 49

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has released clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

Circulation

MARCH 9, 2025

Circulation, Volume 151, Issue 10 , Page e709-e709, March 11, 2025.

Atherosclerosis 45

Atherosclerosis Circulation 45

DAIC

FEBRUARY 3, 2025

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. 2022 Aug, 80 (9) 934946 Kronenberg F.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Circulation

MARCH 23, 2025

Circulation, Volume 151, Issue 12 , Page e765-e765, March 25, 2025.

Article 45

Article Dementia Atherosclerosis Circulation 45

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP288-ATP288, February 1, 2025. Carotid atherosclerosis (CAS) is a critical precursor to atherosclerotic cardiovascular disease and is closely associated with the development and progression of conditions such as stroke and poor prognosis.

Atherosclerosis 40

Atherosclerosis Plaque Stenosis Cardiovascular Disease 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2025. Background:The mechanisms by which intracranial atherosclerosis (ICAS) contributes to large-vessel occlusion strokes (LVOS) remains unclear.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP292-AWP292, February 1, 2025. Background:Intracranial atherosclerosis (ICAS) is a common stroke cause, with a recurrent stroke risk of up to 18% per year despite treatment advances. 0.96; P<0.05, Figure 1c).Conclusions:Lipid-lowering

Atherosclerosis 40

Atherosclerosis Stroke Strokes Hypertension 40

Circulation

APRIL 6, 2025

Circulation, Volume 151, Issue 14 , Page e922-e922, April 8, 2025.

Thrombosis 45

Thrombosis Atherosclerosis Circulation 45

Journal of the American Heart Association

JANUARY 22, 2025

Journal of the American Heart Association, Volume 14, Issue 2 , January 21, 2025. Methods and ResultsData from 6349 adults (aged: 62.2 women) from the MESA study with no prior CVD in 2000 to 2002 (baseline) were used in this analysis.

Atherosclerosis 40

Atherosclerosis Cardiovascular Disease 40

Clinical Trial Results

MARCH 31, 2025

MattBudoffEKSTROM ACC 2025 FINAL Download Disclosures: TBD

Coronary Artery Disease 40

Coronary Artery Disease Download Atherosclerosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP190-AWP190, February 1, 2025. Patients presenting intracranial atherosclerosis-related large vessel occlusion (ICAS-LVO) may benefit from performing an early bailout strategy after failed MT with conventional devices.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Stenosis 40

Cardiometabolic Health Congress

NOVEMBER 25, 2024

On-demand access is available now and will remain open until December 2025. Dyslipidemia, Atherosclerosis & Thrombosis: Explore non-statin therapies, strategies for managing hypertriglyceridemia, and new guidance on lipoprotein(a) management. When Will It Be Available? Ready to Access CMHC On-Demand?

CME 52

CME Obesity Certification Education 52

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Learn more now!

CME 64

CME Innovation Education Atherosclerosis 64

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025. Introduction:Current guidelines do not support the use of stenting for severe symptomatic intracranial atherosclerotic disease (ICAD) over maximal medical therapy (MMT) as first line treatment.

Stroke 40

Stroke Strokes Stent Stents 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP222-ATP222, February 1, 2025. Background:Symptomatic intracranial atherosclerotic disease carries a high stroke recurrence rate. Accurate prediction of stroke recurrence is critical for improving patient outcomes through timely and targeted interventions.

Stroke 40

Stroke Strokes Atherosclerosis Stenosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP311-ATP311, February 1, 2025. Introduction:Immune Checkpoint Inhibitors (ICIs) used for treatment of malignancies might promote atherosclerosis and increase the risk of ischemic stroke (IS).

Cancer 40

Cancer Stroke Strokes Atherosclerosis 40

Stroke Journal

MARCH 23, 2025

Stroke, Volume 56, Issue 4 , Page e114-e118, April 1, 2025. The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.

Angioplasty 40

Angioplasty Stenosis Coronary Artery Disease Stent 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP293-ATP293, February 1, 2025. Background and Objectives:Left subclavian artery (LSA) is more prone to atherosclerosis than the right one. The study was designed to investigate whether aortic arch types (AAT) was associated with the lateralization of subclavian artery stenosis (SAS).Methods:In

Stenosis 40

Stenosis Aortic Atherosclerosis Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP268-AWP268, February 1, 2025. Stroke subtype was examined using TOAST classification: 1) large artery atherosclerosis; 2) cardioembolic; 3) small vessel occlusion; 4) other known etiology (e.g., hematologic disorders or arterial dissection); 5) cryptogenic stroke.

COVID-19 40

COVID-19 Stroke Strokes Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP332-ATP332, February 1, 2025. Introduction:Subclinical hyperthyroidism has been linked to an increased risk of atrial fibrillation, which elevates the likelihood of cardioembolism, cryptogenic stroke (CS), and embolic stroke of undetermined source (ESUS).

Stroke 40

Stroke Strokes Atherosclerosis Atrial Fibrillation 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP8-ATMP8, February 1, 2025. Introduction:The role of alcohol consumption as an independent risk factor for atherosclerosis remains controversial. Carotid intima-media thickness (CIMT) is a recognized marker of atherosclerosis and can serve as a predictor of cardiovascular events.

Atherosclerosis 40

Atherosclerosis Risk Factors Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP23-AWP23, February 1, 2025. Additional data on the evidence of atherosclerosis might be warranted to study the impact of statins on high LDL levels in the presence of atherosclerosis. Introduction:Acute ischemic stroke is the second leading cause of death worldwide. to 0.98, p =0.03).Conclusion:This

Stroke 40

Stroke Strokes Atherosclerosis Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP107-AWMP107, February 1, 2025. Background:Early detection of carotid artery (CA) conditions such as atherosclerosis and dissection are important as they represent major preventable causes of stroke. These patients had varying CA conditions (atherosclerosis, dissection, normal, etc.)

Stenosis 40

Stenosis Atherosclerosis Ultrasound Stroke 40

Cardiometabolic Health Congress

DECEMBER 5, 2024

AHA announced a $12M investment in AI research, with an RFP slated for early 2025. Many of our CMHC faculty who spoke at AHA 2024 are featured in this on-demand program, sharing expertise on key topics in cardiorenal health, obesity, diabetes, dyslipidemia, atherosclerosis, and more. Watch AI-ECHO results. Express interest here.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A36-A36, February 1, 2025. Background:Intracranial atherosclerotic disease (ICAD), a common cause of stroke, is associated with cerebral atrophy and cognitive impairment, but the underlying pathophysiology remains unknown.

Atherosclerosis 40

Atherosclerosis Stroke Strokes Outcomes 40

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP326-ATP326, February 1, 2025. Non-cardioembolic stroke was defined as stroke from large artery atherosclerosis, small vessel disease, or other known mechanism. The primary predictor was stroke subtype (ESUS vs. non-cardioembolic). ESUS was defined using the ESUS consensus criteria.

Stroke 40

Stroke Strokes Atherosclerosis Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP14-ADP14, February 1, 2025. Background:PCSK9, a key regulator of cholesterol metabolism, has been implicated in atherosclerosis. However, its potential role in vascular cognitive impairment and dementia (VCID) remains elusive.

Diet 40

Diet Dementia Atherosclerosis Cholesterol 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP376-AWP376, February 1, 2025. Introduction:Piezo1 is a mechanosensitive ion channel that gates calcium and sodium influx in response to membrane deformation or elevated shear stress.

Atherosclerosis 40

Atherosclerosis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP276-AWP276, February 1, 2025. Patients (age 18 years) with clinical manifestations of arterial disease or risk factors for atherosclerosis were included and classified into the VAH and non-VAH group. Background and Objectives:Vertebral artery hypoplasia (VAH) is a common anatomical variation.

Stenosis 40

Stenosis Atherosclerosis Risk Factors Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP318-ATP318, February 1, 2025. Introduction:Elevated Low-Density-Lipoprotein Cholesterol (LDL-C) blood levels are a risk factor for atherosclerosis. Lipid-lowering therapies mitigate the risk of atherothrombotic events.

Stenosis 40

Stenosis Atherosclerosis Cholesterol Ischemia 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP258-ATP258, February 1, 2025. Introduction:Mechanical thrombectomy (MT) devices were fundamentally designed for the treatment of cardioembolic (CE) strokes despite that 10-20% of large vessel occlusions (LVO) are caused by large artery atherosclerosis (LAA), which may not respond comparably.

Atrial Fibrillation 40

Atrial Fibrillation Plaque Atherosclerosis Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP220-ATP220, February 1, 2025. Patients with clinically defined intracranial atherosclerotic vascular diseases or risk factors of atherosclerosis were available. Patients with ICAS having no or only mild stenosis (30%) of the ipsilateral extracranial ICA (C1) were included.

Stenosis 40

Stenosis Hospital Atherosclerosis Risk Factors 40